Biophysical

Biophysical Therapeutics is a biotechnology company focused on utilizing computational biology and biophysical modeling to design novel therapeutics for cancer and age-related diseases. Founded in 2022 by Michael Forrest, the company leverages a proprietary platform to identify drug candidates that target metabolic processes and mitochondrial function to extend healthspan and lifespan. Their pipeline includes experimentally-validated programs aimed at slowing or reversing the aging process and treating neurodegenerative conditions like Alzheimer's and Parkinson's. The company's approach centers on the biophysical constraints of biological systems to accelerate the discovery of first-in-class small molecule and biologic drugs.